These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38251849)

  • 21. Transforming Cold Tumors into Hot Ones with a Metal-Organic Framework-Based Biomimetic Nanosystem for Enhanced Immunotherapy.
    Xu M; Chang Y; Zhu G; Zhu X; Song X; Li J
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):17470-17484. PubMed ID: 36995264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manganese Dioxide-Entrapping Dendrimers Co-Deliver Protein and Nucleotide for Magnetic Resonance Imaging-Guided Chemodynamic/Starvation/Immune Therapy of Tumors.
    Gao Y; Ouyang Z; Shen S; Yu H; Jia B; Wang H; Shen M; Shi X
    ACS Nano; 2023 Dec; 17(23):23889-23902. PubMed ID: 38006397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy.
    Noh I; Son Y; Jung W; Kim M; Kim D; Shin H; Kim YC; Jon S
    Biomaterials; 2021 Aug; 275():120926. PubMed ID: 34147723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoscale Zeolitic Imidazolate Framework-8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides.
    Zhang H; Chen W; Gong K; Chen J
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31519-31525. PubMed ID: 28841289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice.
    Zhao Y; Wang H; Yang Y; Jia W; Su T; Che Y; Feng Y; Yuan X; Wang X
    Int J Nanomedicine; 2020; 15():9571-9586. PubMed ID: 33293808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy.
    Wang Z; Zhang Y; Liu Z; Dong K; Liu C; Ran X; Pu F; Ju E; Ren J; Qu X
    Nanoscale; 2017 Sep; 9(37):14236-14247. PubMed ID: 28914317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
    Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mn-based cGAS-STING activation for tumor therapy.
    Huang A; Zhou W
    Chin J Cancer Res; 2023 Feb; 35(1):19-43. PubMed ID: 36910853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.
    Zhang J; Wei L; Ma X; Wang J; Liang S; Chen K; Wu M; Niu L; Zhang Y
    Acta Biomater; 2023 Aug; 166():470-484. PubMed ID: 37253416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment.
    Ben Abdelwahed R; Cosette J; Donnou S; Crozet L; Ouakrim H; Fridman WH; Sautès-Fridman C; Mahjoub A; Fisson S
    J Exp Clin Cancer Res; 2013 Apr; 32(1):18. PubMed ID: 23561041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy.
    Li J; Ren H; Qiu Q; Yang X; Zhang J; Zhang C; Sun B; Lovell JF; Zhang Y
    ACS Nano; 2022 Oct; 16(10):16909-16923. PubMed ID: 36200692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy.
    Chen C; Hu M; Cao Y; Zhu B; Chen J; Li Y; Shao J; Zhou S; Shan P; Zheng C; Li Z; Li Z
    Biomacromolecules; 2023 Jun; 24(6):2790-2803. PubMed ID: 37125731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer.
    Gu F; Hu C; Cao W; Li C; Xia Q; Gao Y; Liu Y; Gao S
    Int J Nanomedicine; 2022; 17():4401-4417. PubMed ID: 36164553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Microenvironment-Activated Hydrogel Platform with Programmed Release Property Evokes a Cascade-Amplified Immune Response against Tumor Growth, Metastasis and Recurrence.
    Gong S; Liang X; Zhang M; Li L; He T; Yuan Y; Li X; Liu F; Yang X; Shen M; Wu Q; Gong C
    Small; 2022 Dec; 18(50):e2107061. PubMed ID: 36323618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Modulator and Low-Temperature PTT-Induced Synergistic Immunotherapy for Cancer Treatment.
    Duan Y; Yang H; Gao J; Wei D; Zhang Y; Wang J; Zhang X; Zhang J; Ge K; Wu X; Chang J
    ACS Appl Bio Mater; 2021 Feb; 4(2):1524-1535. PubMed ID: 35014502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy
    Hou L; Tian C; Yan Y; Zhang L; Zhang H; Zhang Z
    ACS Nano; 2020 Apr; 14(4):3927-3940. PubMed ID: 32298077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity.
    Lemos H; Ou R; McCardle C; Lin Y; Calver J; Minett J; Chadli A; Huang L; Mellor AL
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32847988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.